Elvitegravir

CHEMBL204656 Phase 4 Aprovado Small molecule

Half-Life

—

Bioavailability

—

Protein Binding

—

Molecular Weight

447.9 g/mol

LogP

5.3

Phase

4

This antiviral medication blocks an enzyme that the HIV virus needs to insert its genetic material into human cells. It is always used as part of a combination antiretroviral therapy regimen.

Peso Molecular

447,9000 g/mol

LogP

5,30

TPSA

87,10 Å²

Regra dos 5 de Lipinski

Aprovado

Áreas Terapêuticas

Generalized Anxiety Disorder Hypertension HIV/AIDS Hepatitis C

Pharmacokinetics (PK)

Pharmacodynamics (PD)

Estrutura 2D

SVG PNG

Cite this structure

Embed this structure

SMILES

COc1cc2c(cc1Cc1cccc(Cl)c1F)c(=O)c(C(=O)O)cn2[C@H](CO)C(C)C

InChI

InChI=1S/C23H23ClFNO5/c1-12(2)19(11-27)26-10-16(23(29)30)22(28)15-8-14(20(31-3)9-18(15)26)7-13-5-4-6-17(24)21(13)25/h4-6,8-10,12,19,27H,7,11H2,1-3H3,(H,29,30)/t19-/m1/s1

Molecular Formula

C23H23ClFNO5

HBD / HBA

2 / 7

Ligações Rotacionáveis

7

Átomos Pesados

31

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Perguntas frequentes

This antiviral medication blocks an enzyme that the HIV virus needs to insert its genetic material into human cells. It is always used as part of a combination antiretroviral therapy regimen.

Yes, Elvitegravir is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

ChEMBL — European Bioinformatics Institute (EBI). CHEMBL204656. Open-access bioactivity database.
PubChem — National Center for Biotechnology Information (NCBI). CID 5277135. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

PillFYI

Procura informações acessíveis para o paciente?

Elvitegravir no PillFYI

Estrutura

Dados Rápidos

Fórmula: C23H23ClFNO5
Sinônimos: 2

Links Externos

Cite

BibTeX, APA, MLA, Chicago, IEEE, Harvard

Aviso Médico

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.